This document discusses treatment of cancer of the maxilla bone. It begins by describing the anatomy and symptoms of maxillary sinus cancer. Risk factors include occupational exposures, smoking, and chronic sinusitis. Investigations may include imaging and biopsies. Management involves surgery, radiation therapy, or a combination. Radiation techniques have advanced from conventional to 3D conformal and IMRT to better spare nearby organs at risk like the eyes and brain. Doses above 60Gy generally improve outcomes but can cause side effects like dry mouth and optic neuropathy if not carefully planned. Patient immobilization and monitoring during treatment are important.
Introduction
Time dose & fractionation
Therapeutic index
Four R’s Of Radiobiology
Radiation response
Survival Curves Of Early & Late Responding Cells
Various fractionation schedules
Clinical trials of altered fractionation
Introduction
Time dose & fractionation
Therapeutic index
Four R’s Of Radiobiology
Radiation response
Survival Curves Of Early & Late Responding Cells
Various fractionation schedules
Clinical trials of altered fractionation
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
Conventional radiotherapy treatments are delivered with radiation beams that are of uniform intensity across the field (within the flatness specification limits). Wedges or compensators are used to modify the intensity profile to offset contour in irregularities and produce more uniform composite dose distributions such as in techniques using wedges. This process of changing beam intensity profile to meet the goals of a composite plan is called intensity modulation
IMRT refers to a radiation therapy technique in which nonuniform fluence is delivered to the patient from any given position of the treatment beam to optimize the composite dose distribution. The optimal fluence profiles for a given set of beam directions are determined through inverse planning. The fluence files thus generated are electronically transmitted to the linear accelerator, which is computer controlled, to deliver intensity modulated beams (IMBs) as calculated.
EBCTCG METAANALYSIS
INDICATION OF POST OP RADIOTHERAPY
Immobilization devices
Conventional planning
Alignment of the Tangential Beam with the Chest Wall Contour
Doses To Heart & Lung By Tangential Fields
Management of cacrinoma cervix: Techniques of radiotherapy (2D conventional, 3D Conformal radiotherapy (3DCRT) and IMRT with a review of various contouring guidelines.
Conventional radiotherapy treatments are delivered with radiation beams that are of uniform intensity across the field (within the flatness specification limits). Wedges or compensators are used to modify the intensity profile to offset contour in irregularities and produce more uniform composite dose distributions such as in techniques using wedges. This process of changing beam intensity profile to meet the goals of a composite plan is called intensity modulation
IMRT refers to a radiation therapy technique in which nonuniform fluence is delivered to the patient from any given position of the treatment beam to optimize the composite dose distribution. The optimal fluence profiles for a given set of beam directions are determined through inverse planning. The fluence files thus generated are electronically transmitted to the linear accelerator, which is computer controlled, to deliver intensity modulated beams (IMBs) as calculated.
EBCTCG METAANALYSIS
INDICATION OF POST OP RADIOTHERAPY
Immobilization devices
Conventional planning
Alignment of the Tangential Beam with the Chest Wall Contour
Doses To Heart & Lung By Tangential Fields
Protocol of Dental Treatment in Radiotherapy Indicated Patients.pptxHoor-E-Jannath Prity
The dental management of patients who are to or have received radiotherapy pose a great challenge for general dentists. It is very important that we adhere to the established treatment regime to avoid any complications that may occur because of unplanned dental treatments.
Side effects of radiation in head and neck cancerAnagha pachat
this presentation describes how radiation effects normal structures in head and neck region and about the late and acute toxicities which may occur if the radiation exceeds tolerance dose as per QUANTEC
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Ca Maxilla - Radiation Therapy
1. TREATMENT OF CA MAXILLA
Presenter:- Aaditya Sinha
M.Sc Radiotherapy Technology
2. MAXILLARY SINUS
The maxillary sinus is one of the four paranasal sinuses, which
are located near the nose. The maxillary sinus is the largest of
the paranasal sinuses. The two maxillary sinuses are located
below the cheeks, above the teeth and on the sides of the nose.
Function: Decreasing the relative weight of the front of the skull,
and especially the bones of the face. Increasing resonance of
the voice.
3. ANATOMY
The maxillary sinuses are shaped like a pyramid and each contain three
cavities, which point sideways, inwards, and downwards. The sinuses are
small air-filled holes found in the bones of the face.
They reduce skull weight, produce mucus, and affect the tone quality of a
person's voice.
4. Symptoms of Ca Maxilla
In the early stages of the disease, symptoms may be
totally absent. Another practical problem that makes
an early detection difficult is that, symptoms if present
are not specific.
• Headaches
• Pain in the sinus areas on either sides of the nose
• Runny nose
• Nosebleeds
• Lump or sore inside the nose that does not heal
• Numbness of cheeks
• Pain in the upper teeth
• Loose teeth
• Dentures that no longer fit well
• Swelling or other difficulties with the eyes
5. Risk Factors
The following conditions may predispose a person to increased risk of
developing a maxillary sinus cancer. Exposure to certain workplace chemicals
or dust
• Work in Furniture-making
• Carpentry
• Shoemaking
• Metal-plating
• Flour mill or bakery work
• Age more than 40 years
• Smoking; Tobacco use
• Chronic sinusitis
9. RADIOTHERAPY
Addition of RT to surgery improve 5-years survival (44%) when
compared to RT alone (23%) or surgery alone.
Indications:
Definitive : medically inoperable or who refuse radical surgery or
early lesions.
Pre- and postoperative radiation may result in similar control
rates, but post-operative RT preferred:
Preoperative radiation increases the infection rate and the risk of
postoperative wound complications.
It may obscure the initial extent of disease or surgery can not
remove the microscopic extensions of the tumor.
• Postoperative radiation therapy is started 4 to 6 weeks after
surgery.
12. • Field Margins:
A three-field technique for maxillary antrum: 1 anterior and 2
lateral fields.
Anterior field:
superior border: above the crista galli to encompass the ethmoids in the
absence of orbital invasion, at the lower edge of the cornea to cover the
orbital floor.
inferior border: 1 cm below the floor of the sinus.
lateral border: 1 cm beyond the apex of the sinus or falling off the skin.
Lateral fields:
superior border: follows the floor of anterior cranial fossa.
anterior border: behind the lat canthus parallel to the slope of face.
posterior border: covers the pterygoid plates.
13. CONVENTIONAL: 3 field technique
Patient lies in a supine cast
with the head in neutral position.
Tongue bite is used to depress
tongue & lower alveolus away
from the target volume.
15. RT Dose
• Dose prescribed at depth of 5 cm
• EBRT dose
- Pre operative : 45-50 Gy over 5 wks
- Post operative : 55-60 Gy over 5.5 – 6 wks
16. 3D-CRT
3 Field tech is used:
1. Anterior 2. two lateral portal
*Electron beam may be used for boost purpose.
17. • Initial target volume – Post op. RT
- Sx bed + 1-2 cm margin
- Boost volume – areas at high risk for recurrence
• Advantage
- spare retina & optic nerve
- Post op dose of 66 Gy can be delivered
18. TARGET VOLUME DELINEATION
The CTV should encompass
• all initial sites of disease(presurgery GTV),
• The mucosa of adjacent compartments of the sinonasal
complex and a 10 mm margin at least from initial sites of GTV
where no good bony barrier to invasion exists (e.g. masticator
space, cribriform plate and infraorbital fissure)
For most tumors, the CTV will include the ipsilateral maxillary
sinus and bilateral nasal cavity and the ethmoid sinuses.
The CTV is expanded isotropically (usually by 3–5 mm)to form
the PTV
19. ORGAN AT RISK
1. Eye Lenses
2. Lacrimal glands
3. Optic nerves and chiasm
4. Spinal cord
5. Brainstem and
6. Pituitary gland
20. OAR & Possible Complications of RT
• Lens <10 Gy (cataracts) during the total dose delivery of 60 Gy.
• Lacrimal gland <30–40 Gy (dry eye syndrome)
• Retina <45 Gy (blindness)
• Optic chiasm and nerves <54 Gy at standard fractionation. (Optic
neuropathy)- It is the damage to optic nerve by an external factor
by damaging it neurons leads to loss of vision, with washed out
color visibilty.
• Brain <60 Gy (necrosis)
• Mandible <60 Gy (osteoradionecrosis)-Bone death due to
radiation, bone dies because radiation damages its blood vessels.
It’s a late effect.
• Parotid mean dose <26 Gy (xerostomia) – Unusual dry mouth
basically from medicines.
• Pituitary and hypothalamus mean dose <40 Gy.
21. IMRT
A non-coplanar arrangement
of three to five sagittal midline
beams with right and left
lateral beams avoids entry or exit of
beams through the eyes and
provides a uniform dose distribution
IMRT has been shown to be useful in
reducing long-term toxicity by
reducing the dose to salivary glands,
temporal lobes, auditory structures,
and optic structures
23. Dose fractionation (D/Fx)
Definitive RT: 70Gy , 2 Gy/# over 7 wks
Adjuvant
60 Gy in 30 daily fractions given in 6 weeks.
66 Gy in 33 daily fractions if possible where there is residual
disease.
Palliative
36 Gy in 6 fractions of 6 Gy treating once weekly.
24. Treatment delivery and patient care
Patients are seen weekly during treatment :
• Exercises to reduce trismus
• Prophylactic feeding tubes should be considered
• Ophthalmic review .
• Lubricating eye ointments.
• If there is a pre-existing facial nerve palsy, the eyelid should
be taped shut at night to avoid a dry eye.
• Pituitary function tests should be carried out annually during
follow-up to evaluate late RT effects to the pituitary gland.
25. CONCLUSION:
• Radiotherapy is a best treatment for Ca maxilla.
• Uniform dose distribution can achieve by RT(3D-CRT & IMRT).
• Minimize dose to the critical organs.
• Minimize set up errors by using immobilization devices.
• During the treatment eyes should be faced toward the gantry.
• Patient specific Q.A. should be done before the IMRT treatment.